drugset / Trial / NCT04676776
Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"
Phase 2
Unknown
139 enrolled
Gynuity Health Projects
Cuidado Integral de la Mujer, Gineclinic, S.C. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the effectiveness and acceptability of a 3-day missed period pill regimen.
Timeline
- Start
- 2021-01-25
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 1.5 mg | — |
| Subject | Mifepristone | Small molecule | 200 mg | — |
Indications
No indication recorded.